[go: up one dir, main page]

Mitrovich et al., 2025 - Google Patents

Genetically recoding respiratory syncytial virus to visualize nucleoprotein dynamics and virion assembly

Mitrovich et al., 2025

View HTML
Document ID
16126176153952887109
Author
Mitrovich M
Vahey M
Publication year
Publication venue
ACS Infectious Diseases

External Links

Snippet

RNA viruses possess small genomes encoding a limited repertoire of essential and often multifunctional proteins. Although genetically tagging viral proteins provides a powerful tool for dissecting mechanisms of viral replication and infection, it remains a challenge. Here, we …
Continue reading at pubs.acs.org (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions

Similar Documents

Publication Publication Date Title
US10352945B2 (en) Optogenetic probes for measuring membrane potential
Cross et al. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics
Noton et al. Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions
Garrus et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding
Lavado-García et al. Multiplexed quantitative proteomic analysis of HEK293 provides insights into molecular changes associated with the cell density effect, transient transfection, and virus-like particle production
Sanz et al. Translation of Sindbis Subgenomic mRNA is Independent of eIF2, eIF2A and eIF2D
Han et al. Host factor Rab11a is critical for efficient assembly of influenza A virus genomic segments
JP2010523130A (en) RNA interference tag
Garcia‐Moreno et al. Requirements for eIF 4 A and eIF 2 during translation of S indbis virus subgenomic mRNA in vertebrate and invertebrate host cells
Ma et al. Real-time imaging of single HIV-1 disassembly with multicolor viral particles
Yang et al. Defining viral defective ribosomal products: standard and alternative translation initiation events generate a common peptide from influenza A virus M2 and M1 mRNAs
Boeynaems et al. Poly (A)-binding protein is an ataxin-2 chaperone that regulates biomolecular condensates
Lei et al. Initiation of HIV-1 Gag lattice assembly is required for recognition of the viral genome packaging signal
Brandariz-Nunez et al. Avian reovirus μNS protein forms homo-oligomeric inclusions in a microtubule-independent fashion, which involves specific regions of its C-terminal domain
Rehman et al. Emerging biomedical applications of the vesicular stomatitis virus glycoprotein
Bowen et al. Discovery of membrane-permeating cyclic peptides via mRNA display
Wang et al. Ac106/107 affects production of infectious progeny BV by regulating transcription of late viral genes and host cell energy metabolism
Agosto et al. A positive-feedback mechanism promotes reovirus particle conversion to the intermediate associated with membrane penetration
Mitrovich et al. Genetically recoding respiratory syncytial virus to visualize nucleoprotein dynamics and virion assembly
Lau et al. Rapid HIV-1 capsid interaction screening using fluorescence fluctuation spectroscopy
Fu et al. Guest sequence can influence RNA encapsulation by an engineered cationic protein capsid
Ma et al. Single-particle tracking reveals the interplay between HIV-1 reverse transcription and uncoating
EP4413121A1 (en) Cell hybrids as host cells for high efficiency production of gene therapy vectors and viral vaccines
Sakamoto et al. Strategy toward in-cell self-assembly of an artificial viral capsid from a fluorescent protein-modified β-annulus peptide
Vazquez-Calvo et al. Plasma membrane phosphatidylinositol 4, 5 bisphosphate is required for internalization of foot-and-mouth disease virus and vesicular stomatitis virus